Irreversible Electroporation (IRE), over the last few years, has established itself as a novel method in the field of focal cancer ablation in many medical institutions worldwide. Based on a non-thermal technology, IRE destroys cells whilst preserving non-cellular tissue elements within the treatment field. This property makes IRE a gentle alternative for focal treatments of prostate cancer, as structures such as nerves, sphincters and the rectum are preserved. The functionality and preservation of these structures are frequently compromised when prostate cancer is treated with other, more radical therapies, which can lead to impotence and incontinence. In view of the fact that prostate cancer is the second most common cancer in men worldwide, the gentle approach of IRE has the potential to permanently change the way prostate cancer is treated. An article about IRE was now published by our team in the German journal for oncology “Thieme”.